Wall Street brokerages forecast that Medical Properties Trust, Inc. (NYSE:MPW) will post $196.89 million in sales for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Medical Properties Trust’s earnings. The lowest sales estimate is $181.65 million and the highest is $206.38 million. Medical Properties Trust posted sales of $176.58 million during the same quarter last year, which suggests a positive year over year growth rate of 11.5%. The firm is scheduled to issue its next earnings results on Thursday, November 1st.

According to Zacks, analysts expect that Medical Properties Trust will report full-year sales of $803.31 million for the current year, with estimates ranging from $760.06 million to $836.00 million. For the next financial year, analysts anticipate that the firm will report sales of $813.28 million, with estimates ranging from $750.39 million to $890.00 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.30 EPS for the quarter, missing the Zacks’ consensus estimate of $0.36 by ($0.06). The company had revenue of $201.90 million during the quarter, compared to analyst estimates of $206.72 million. Medical Properties Trust had a net margin of 44.46% and a return on equity of 9.12%. The firm’s revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period last year, the firm earned $0.32 EPS.

A number of research analysts recently commented on the company. JMP Securities set a $16.00 price target on Medical Properties Trust and gave the company a “buy” rating in a research note on Monday, October 1st. Jefferies Financial Group downgraded Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 price target for the company. in a research note on Tuesday, July 17th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. Medical Properties Trust has a consensus rating of “Hold” and an average target price of $14.31.

MPW stock traded up $0.09 during midday trading on Friday, reaching $14.64. The company had a trading volume of 129,100 shares, compared to its average volume of 2,072,780. The company has a market cap of $5.44 billion, a PE ratio of 10.81, a price-to-earnings-growth ratio of 3.10 and a beta of 0.55. Medical Properties Trust has a 1-year low of $11.82 and a 1-year high of $15.24. The company has a quick ratio of 2.19, a current ratio of 2.19 and a debt-to-equity ratio of 1.26.

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 11th. Shareholders of record on Thursday, September 13th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 6.83%. The ex-dividend date was Wednesday, September 12th. Medical Properties Trust’s payout ratio is 74.07%.

In other Medical Properties Trust news, Director Michael G. Stewart sold 12,400 shares of the business’s stock in a transaction dated Friday, October 12th. The stock was sold at an average price of $14.13, for a total transaction of $175,212.00. Following the completion of the transaction, the director now owns 231,039 shares of the company’s stock, valued at $3,264,581.07. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider R Steven Hamner sold 35,000 shares of the business’s stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $14.73, for a total value of $515,550.00. Following the transaction, the insider now directly owns 1,114,044 shares of the company’s stock, valued at approximately $16,409,868.12. The disclosure for this sale can be found here. In the last three months, insiders have sold 165,809 shares of company stock valued at $2,456,679. Insiders own 0.83% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Sandler Capital Management grew its holdings in shares of Medical Properties Trust by 9.5% during the second quarter. Sandler Capital Management now owns 70,600 shares of the real estate investment trust’s stock worth $991,000 after purchasing an additional 6,100 shares during the last quarter. Private Advisor Group LLC grew its holdings in shares of Medical Properties Trust by 26.5% during the second quarter. Private Advisor Group LLC now owns 60,728 shares of the real estate investment trust’s stock worth $849,000 after purchasing an additional 12,725 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Medical Properties Trust by 10.2% during the second quarter. Bank of New York Mellon Corp now owns 9,096,460 shares of the real estate investment trust’s stock worth $127,715,000 after purchasing an additional 840,443 shares during the last quarter. First Republic Investment Management Inc. bought a new stake in shares of Medical Properties Trust during the second quarter worth about $1,093,000. Finally, Federated Investors Inc. PA grew its holdings in shares of Medical Properties Trust by 24.9% during the second quarter. Federated Investors Inc. PA now owns 149,519 shares of the real estate investment trust’s stock worth $2,099,000 after purchasing an additional 29,802 shares during the last quarter. 77.02% of the stock is owned by hedge funds and other institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Story: The benefits and drawbacks of dollar cost averaging

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.